Results 101 to 110 of about 8,412,464 (305)

Portal Hypertension and a Stiff Liver. [PDF]

open access: yes, 2018
Portal hypertension (PH) is a common clinical syndrome leading to severe complications. In the western world, about 90% of cases of PH are due to liver cirrhosis, and thanks to the availability of ultrasound elastography methods, this diagnosis is ...
Felicia D'Alitto   +13 more
core   +2 more sources

Surgical Considerations in Portal Hypertension. [PDF]

open access: yes
This review provides an in-depth exploration of portal hypertension (PH) and its implications in various surgical procedures. The prevalence of clinically significant PH is 50% to 60% in compensated cirrhosis and 100% in decompensated cirrhosis.
Berzigotti, Annalisa   +6 more
core   +1 more source

Neuropeptide Y restores non-receptor-mediated vasoconstrictive action in superior mesenteric arteries in portal hypertension [PDF]

open access: yes, 2015
BACKGROUND & AIMS Vascular hyporeactivity to vasoconstrictors contributes to splanchnic arterial vasodilatation and hemodynamic dysregulation in portal hypertension.
Müller-Schilling, Martina   +5 more
core   +1 more source

CAQ Corner: Basic concepts of transplant immunology

open access: yes, 2022
Liver Transplantation, EarlyView.
Amanda Cheung, Josh Levitsky
wiley   +1 more source

VACTERL (vertebral anomalies, anal atresia or imperforate anus, cardiac anomalies, tracheoesophageal fistula, renal and limb defect) spectrum presenting with portal hypertension: a case report

open access: yesJournal of Medical Case Reports, 2010
Introduction We report for the first time a unique case of VACTERL (vertebral anomalies, anal atresia or imperforate anus, cardiac anomalies, tracheoesophageal fistula, renal and limb defect) spectrum associated with portal hypertension.
Losa Ignatius, Bhurtel Dilli
doaj   +1 more source

Emerging non-invasive approaches for diagnosis and monitoring of portal hypertension.

open access: yes, 2018
Clinically significant portal hypertension is associated with an increased risk of developing gastro-oesophageal varices and hepatic decompensation.
Berzigotti, Annalisa   +3 more
core   +1 more source

CAQ Corner: Immune‐mediated complications

open access: yes, 2022
Liver Transplantation, EarlyView.
Mary Thomson, John R. Lake
wiley   +1 more source

Failure of Splenectomy to Ameliorate Portal Hypertension in Myeloproliferative Disorders

open access: yesCanadian Journal of Gastroenterology, 1994
The correct treatment of portal hypertension associated with myeloproliferative disorders remains uncertain. Splenectomy has been advocated by some to eliminate the forward flow component of the portal hypertension and thus reduce portal pressure.
Samuel S Lee   +4 more
doaj   +1 more source

Tibolone Use Associated With Elevated Hepatocellular Carcinoma Risk: Findings From a Nationwide Cohort

open access: yesInternational Journal of Cancer, EarlyView.
ABSTRACT Tibolone, a synthetic steroid with estrogenic, progestogenic, and androgenic activity, is widely prescribed for menopausal symptoms, but its association with hepatocellular carcinoma (HCC) remains unclear. Using data from 117,271 women aged ≥ 45 years in the Korean National Health Insurance Service–Health Screening Cohort, we evaluated ...
Jimin Lee   +9 more
wiley   +1 more source

Stories behind the cover

open access: yesPortal Hypertension & Cirrhosis, 2023
Editorial Office
doaj   +1 more source

Home - About - Disclaimer - Privacy